Skip to content

Eprosartan

Angiotensin 2 Receptor Blocker — CARDIOVASCULAR SYSTEM

Also known as: eprosartan mesilate, eprosartan mesylate, SKF-108566

OfmFDA approvedATC C09CA02ATC C09DA02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Eprosartan is an ofm drug in the Angiotensin 2 Receptor Blocker class catalogued in DrugCentral. It was first approved by the FDA in 1997. Its mechanism of action is classified as Angiotensin 2 Receptor Antagonists. DrugCentral lists 5 molecular targets, including Agtr1b, Agtr2 and Agtr1|Agtr1b. Recorded indications include Hypertensive disorder.

  • Approval status: ofm (first approved 1997 by the FDA).
  • Drug class: Angiotensin 2 Receptor Blocker.
  • Mechanism of action: Angiotensin 2 Receptor Antagonists.
  • Molecular targets: Agtr1b, Agtr2, Agtr1|Agtr1b and Agtr1|Agtr1b|Agtr2 (5 listed in DrugCentral).
  • Indications: Hypertensive disorder.
  • ATC code: C09CA02 (Angiotensin II receptor blockers (ARBs), plain).
  • Molecular formula: C23H24N2O4S; molecular weight 424.52 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hypertensive disorder

Off-label uses (5)

  • Atrial fibrillation
  • Chronic heart failure
  • Diabetic renal disease
  • Diastolic heart failure
  • Nondiabetic Proteinuric Nephropathy

Contraindications (24)

  • Acute pancreatitis
  • Anuria
  • Azotemia
  • Dehydration
  • Diabetes mellitus
  • Gout
  • Hepatic coma
  • Hypercalcemia
  • Hypercholesterolemia
  • Hyperkalemia
  • Hyperparathyroidism
  • Hyperuricemia
  • Hypochloremic alkalosis
  • Hypokalemia
  • Hypomagnesemia
  • Hyponatremia
  • Hypovolemia
  • Low blood pressure
  • Neonatal hyperbilirubinemia
  • Pregnancy, function
  • Renal artery stenosis
  • Secondary angle-closure glaucoma
  • Sympathectomy
  • Systemic lupus erythematosus

Mechanism & targets

Mechanism of action (MoA)Angiotensin 2 Receptor Antagonists
Established pharmacologic classAngiotensin 2 Receptor Blocker

Molecular targets (5)

TargetGeneActionActivity
Type-1B angiotensin II receptorAgtr1bunknownIC50 9.00
Type-2 angiotensin II receptorAgtr2unknownIC50 9.00
Angiotensin II receptor (AT-1) type-1Agtr1|Agtr1bunknownIC50 9.00
Angiotensin II receptorAgtr1|Agtr1b|Agtr2unknownIC50 9.00
Type-1 angiotensin II receptorAGTR1antagonistIC50 8.70

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1997-12-22FDA—ABBVIE

ATC classification

ATC codeTherapeutic hierarchy
C09CA02CARDIOVASCULAR SYSTEM › AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN › Angiotensin II receptor blockers (ARBs), plain
C09DA02CARDIOVASCULAR SYSTEM › AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS › Angiotensin II receptor blockers (ARBs) and diuretics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Splenic rupture38.3
Splenic haemorrhage31.9
Toxic skin eruption31.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Eprosartan is on its molecule page.

Molecular formulaC23H24N2O4S
Molecular weight424.52 g/mol
CAS number133040-01-4
InChIKeyOROAFUQRIXKEMV-LDADJPATSA-N
PubChem CID5281037
CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Eprosartan used for?

DrugCentral lists the following indications for Eprosartan: Hypertensive disorder.

How does Eprosartan work?

Eprosartan is classified as Angiotensin 2 Receptor Antagonists; its molecular targets in DrugCentral include Agtr1b, Agtr2, Agtr1|Agtr1b and Agtr1|Agtr1b|Agtr2.

When was Eprosartan first approved?

Eprosartan was first approved by the FDA in 1997.

What drug class does Eprosartan belong to?

Eprosartan is in the Angiotensin 2 Receptor Blocker class.

What is the chemical formula of Eprosartan?

Eprosartan has the molecular formula C23H24N2O4S and a molecular weight of 424.52 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1997-12-22
AgencyFDA
Targets5
Indications1
FormulaC23H24N2O4S
DrugCentral ID1037
Interactive profile